Amedeo's Top 20

Amedeo Smart

Independent Medical Education

19 September 2022

Multidisciplinary Journal Club

  1. Hoffmann HM.
    Boosting cognition with a hormone.
    Science 2022;377:1042-1043.

  1. Oldgren J, Asberg S, Hijazi Z, Wester P, et al.
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation 2022.

  2. Shoamanesh A, Mundl H, Smith EE, Masjuan J, et al.
    Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
    Lancet 2022.

  3. Georgianos PI, Tziatzios G, Roumeliotis S, Vaios V, et al.
    Effect of angiotensin converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
    Nephrol Dial Transplant 2022.

  4. Lyes M, Yang KH, Castellanos J, Furnish T, et al.
    Microdosing psilocybin for chronic pain: a case series.
    Pain 2022.

  1. Boulenoir N, Turc G, Ter Schiphorst A, Heldner MR, et al.
    Should Patients With Acute Minor Ischemic Stroke With Isolated Internal Carotid Artery Occlusion Be Thrombolysed?
    Stroke 2022.

  2. Kim D, Yang PS, You SC, Jang E, et al.
    Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study.
    Ann Intern Med 2022.

  3. Zhou H, Wu J, Shi L, Wang Y, et al.
    Analysis of delayed surgery and clinical outcomes in intermediate- and high-risk papillary thyroid cancer.
    J Clin Endocrinol Metab 2022.

  4. Eastell R, Vittinghoff E, Lui LY, Ewing SK, et al.
    Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk.
    J Bone Miner Res 2022.

  5. Capanna M, Signori A, Sormani MP.
    Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials.
    Mult Scler 2022;28:1744-1751.

  1. Ford CC, Cohen JA, Goodman AD, Lindsey JW, et al.
    Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
    Mult Scler 2022;28:1729-1743.

  2. Cortes-Penfield N, Ryder JH.
    Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
    Clin Infect Dis 2022.

  3. Leslie WD, Morin SN, Lix LM, McCloskey EV, et al.
    Effect of Discordant Hip Bone Density on Incident Fracture Risk: A Registry-Based Cohort Study.
    J Bone Miner Res 2022.

  4. Fan W, Machado M, Leder BZ, Beyer L, et al.
    Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
    J Clin Endocrinol Metab 2022.

  5. Park H, Heo J, Kim MJ, Lee JH, et al.
    The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
    Epilepsia 2022.

  1. Xie W, Cao M, Zhong Z, Huang Z, et al.
    Survival outcomes for breast conserving surgery versus mastectomy among elderly women with breast cancer.
    Breast Cancer Res Treat 2022.

  2. Sorensen IMH, Bjergfelt SS, Hjortkjaer HO, Kofoed KF, et al.
    Coronary and extra-coronary artery calcium scores as predictors of cardiovascular events and mortality in chronic kidney disease stages 1-5: a prospective cohort study.
    Nephrol Dial Transplant 2022.

  3. Moens A, Alsoud D, Verstockt B, Sabino J, et al.
    Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center.
    Eur J Gastroenterol Hepatol 2022;34:1015-1020.

  4. Stangl BL, Vogt EL, Blau LE, Ester CD, et al.
    Pharmacodynamic determinants of hangover: An intravenous alcohol self-administration study in non-dependent drinkers.
    Addict Behav 2022;135:107428.

  5. Leone JP, Hassett MJ, Leone J, Tolaney SM, et al.
    Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer.
    Cancer 2022.


more..

Privacy Policy